{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:02:32Z","timestamp":1790344952114,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijtb.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:12:48Z","timestamp":1786464768000},"page":"S206-S211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["Corporate TB pledge: Strategic corporate engagement initiative towards India's end TB efforts"],"prefix":"10.1016","volume":"73","author":[{"given":"Jyoti","family":"Jaju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Kumar","family":"Mattoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Shadab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu E.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3651-0507","authenticated-orcid":false,"given":"Midhun","family":"Rajiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreeja","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tripti","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulshan","family":"Borah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankar","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Alavadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavin","family":"Vadera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"PS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2026.08.003_bib1","series-title":"Global Tuberculosis Report 2025","year":"2025"},{"key":"10.1016\/j.ijtb.2026.08.003_bib2","series-title":"NATIONAL STRATEGIC PLAN FOR TUBERCULOSIS: 2017-25 ELIMINATION BY 2025","year":"2017"},{"issue":"9979","key":"10.1016\/j.ijtb.2026.08.003_bib3","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO's new end TB strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijtb.2026.08.003_bib4","unstructured":"UNAIDS.https:\/\/www.unaids.org\/en\/resources\/presscentre\/featurestories\/2011\/april\/20110406heineken.2011.BusinesssectorcanplaykeyroleintheAIDSresponseinAfrica."},{"key":"10.1016\/j.ijtb.2026.08.003_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdisas.2019.100020","article-title":"Risk informed and resilient development: engaging the private sector in the era of the sendai framework","volume":"2","author":"Abe","year":"2019","journal-title":"Prog Disaster Sci"},{"key":"10.1016\/j.ijtb.2026.08.003_bib6","series-title":"Annual Report 2024 - 2025 Corporate Governance","year":"2025"},{"key":"10.1016\/j.ijtb.2026.08.003_bib7","article-title":"Harnessing the energy of the corporate sector to end TB: BE health","volume":"21","author":"Bettex","year":"2020","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.ijtb.2026.08.003_bib8","series-title":"Central TB Division","article-title":"TB free workplace: guidance document","year":"2024"},{"key":"10.1016\/j.ijtb.2026.08.003_bib9","series-title":"THE COMPANIES ACT, 2013","year":"2013"},{"key":"10.1016\/j.ijtb.2026.08.003_bib10","unstructured":"https:\/\/www.csr.gov.in\/content\/csr\/global\/master\/home\/home.html accessed on February 2026."},{"key":"10.1016\/j.ijtb.2026.08.003_bib11","series-title":"Federation of Indian Chambers of Commerce & Industry","year":"2016"},{"key":"10.1016\/j.ijtb.2026.08.003_bib12","series-title":"Best Practices Compendium Innovative Approaches by Corporates to Eliminate TB by 2025","author":"Gupta","year":"2021"},{"issue":"1","key":"10.1016\/j.ijtb.2026.08.003_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/17441692.2023.2216321","article-title":"Not business as usual: engaging the corporate sector in India's TB elimination efforts","volume":"18","author":"Carwile","year":"2023","journal-title":"Glob Public Health"},{"key":"10.1016\/j.ijtb.2026.08.003_bib14","series-title":"INDIA TB REPORT 2024","year":"2024"},{"issue":"10","key":"10.1016\/j.ijtb.2026.08.003_bib15","first-page":"869","article-title":"Socio-economic impact of tuberculosis on patients and family in India","volume":"3","author":"Rajeswari","year":"1999","journal-title":"Int J Tubercul Lung Dis"},{"issue":"52","key":"10.1016\/j.ijtb.2026.08.003_bib16","first-page":"188","article-title":"Costs to patients with tuberculosis treated under DOTS programme","volume":"52","author":"Muniyandi","year":"2005","journal-title":"Indian J Tubercul"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001957072600226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001957072600226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:25:49Z","timestamp":1790342749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001957072600226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":16,"alternative-id":["S001957072600226X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2026.08.003","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corporate TB pledge: Strategic corporate engagement initiative towards India's end TB efforts","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Tuberculosis Association of India. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}